Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2015 Jul 28;593(Pt 18):4129–4138. doi: 10.1113/JP270575

Structure and gating of CLC channels and exchangers

Alessio Accardi 1,
PMCID: PMC4594288  PMID: 26148215

Abstract

Since their serendipitous discovery the CLC family of Cl transporting proteins has been a never ending source of surprises. From their double-barrelled architecture to their complex structure and divergence as channels and transporters, the CLCs never cease to amaze biophysicists, biochemists and physiologists alike. These unusual functional properties allow the CLCs to fill diverse physiological niches, regulating processes that range from muscle contraction to acidification of intracellular organelles, nutrient accumulation and survival of bacteria to environmental stresses. Over the last 15 years, the availability of atomic-level information on the structure of the CLCs, coupled to the discovery that the family is divided into passive channels and secondary active transporters, has revolutionized our understanding of their function. These breakthroughs led to the identification of the key structural elements regulating gating, transport, selectivity and regulation by ligands. Unexpectedly, many lines of evidence indicate that the CLC exchangers function according to a non-conventional transport mechanism that defies the fundamental tenets of the alternating-access paradigm for exchange transport, paving the way for future unexpected insights into the principles underlying active transport and channel gating.


The long and winding road towards understanding chloride transport across biological membranes has resembled the CLC Cl permeation pathway, where unusual structural twists give rise to divergent functional properties with unexpected functional consequences. From their double-barrelled architecture (Miller, 1982) to their uniquely complex structure (Dutzler et al. 2002) and the unexpected functional split into channels and transporters (Accardi & Miller, 2004), the CLCs have been a never ending source of puzzles and surprises. Their physiological importance is underscored by their involvement in a number of processes which range from controlling the excitability of skeletal muscle fibres to the regulation of epithelial salt reabsorption and the acidification of intracellular compartments. Mutations in at least six of the nine human CLC genes cause genetically inherited pathologies of muscle, bone and kidney (Jentsch, 2008), further highlighting the central roles played by the CLCs in human physiology. In the present review I will describe the insights that followed the landmark resolution of the first CLC crystal structure, CLC-ec1 from Escherichia coli (Dutzler et al. 2002). I will focus on the current mechanistic understanding of how these channels and transporters achieve their fundamental function: mediating the regulated movement of Cl ions across biological membranes.

Structure of the transmembrane region of the CLC exchangers

Over the last 13 years the high-resolution crystal structures of four CLC exchangers have revealed the structural organization of the CLCs and elucidated the molecular basis of anion binding and transport. Three of these four homologues are from prokaryotic organisms, CLC-ec1, CLC-st1 (Dutzler et al. 2002, 2003) and CLC-cy1 (Jayaram et al. 2011), while the fourth, cmCLC (Feng et al. 2010, 2012), is from the thermophilic alga Cyanidioschyzon merolae. The structures of these four family members are nearly identical (Fig. 1A–C), apart from the position of a critical glutamate residue found within the ion permeation pathway (Fig. 1D–E). Remarkably, the structures of these CLC exchangers shed profound insights into the transport and gating of the CLC channels, indicating that the two subtypes share a common structural fold despite functioning according to opposite thermodynamic paradigms.

Figure 1.

Figure 1

Structure of the CLCs

A, structure of the CLC-ec1 dimer viewed from the plane of the membrane. The internal symmetry repeats of the left monomer are shown in blue and cyan. Cl ions are shown as magenta spheres. Neighbouring helices A and R from opposing subunits are labelled. B, surface representation of a CLC-ec1 monomer viewed from the intracellular side to highlight the contribution of the internal symmetry repeats to the formation of the ion transport pathway. The repeats and Cl ions are coloured as in A. C, structure of the cmCLC dimer viewed from the plane of the membrane. D–F, close up views of the three conformations of the ion binding region of WT CLC-ec1 (D), E148Q CLC-ec1 (E) and WT cmCLC (F). Gluex is shown in magenta, Tyrcen and Sercen are shown in cyan and the Cl ions are shown as green spheres. PDB ID: WT CLC-ec1 (1OTS), E148Q CLC-ec1 (1OTU) and WT cmCLC (3ORG).

Consistent with previous biochemical and electrophysiological data (Ludewig et al. 1996; Middleton et al. 1996; Maduke et al. 1999) all CLCs assemble, function and crystallize as homodimers (Fig. 1A and C). Unexpectedly, recent work has shown that CLC-ec1 can also fold, exist in a membrane and function as a monomer (Robertson et al. 2010). Whether all – or any other – CLC homologues can be split into their monomeric constituents while preserving function remains to be seen. Each subunit comprises 18 α-helices, helices A–R, which form an internal antiparallel repeat (Fig. 1A and B), reminiscent of those found in many other transport proteins (Fu et al. 2000; Yernool et al. 2003; Yamashita et al. 2005; Forrest & Rudnick, 2009; Forrest et al. 2011). The first and last helices, A and R, are amphipathic and helix A from one subunit contacts helix R of the other in a small domain swap (Fig. 1A). The functional implications of this interaction are unclear as in the crystal structure of the CLC-ec1 monomer, helix A faces the inter-subunit interface in a drastically different conformation (Robertson et al. 2010), with little impact on function. Furthermore, in cmCLC helix A is not resolved and therefore its position within the context of a full-length CLC homologue is unclear. The remaining 16 transmembrane helices form the Cl transport pathway at the interface between the two internal repeats (Fig. 1B).

The anion transport pathway

Each CLC monomer forms three anionic binding sites (Fig. 1D–F): ions bound to the internal and external sites, Sin and Sex, are directly exposed to the intra- and extracellular solutions, respectively. The central site, Scen, is located near the centre of the bilayer and is shielded from extracellular water molecules by a conserved glutamate, Gluex, and is cut-off from the intracellular solution by a constriction formed by the side chains of a conserved serine, Sercen, and tyrosine, Tyrcen (Fig. 1D). Sex and Scen can be alternatively occupied by a dehydrated Cl ion or by the, presumably deprotonated, side chain Gluex. The ion binding region can exist in three different conformations (Fig. 1D–F), which differ almost exclusively for the position of Gluex. In WT CLC-ec1 (Fig. 1D) a Cl ion occupies Scen and Gluex occupies Sex and occludes the conduction pathway towards the outside. The structure of the E148Q mutant of CLC-ec1 (Fig. 1E), which presumably reflects the state assumed by the pathway when E148 becomes protonated, shows a conformation in which the Q148 side chain moves out of the pathway, opening it towards the extracellular solution, and all three binding sites are occupied by Cl ions. This state is also thought to reflect the open conformation of the CLC channels, consistent with the finding that the charge-neutralized mutants of Gluex in CLC-0, -1 and -2 are constitutively open channels (Dutzler et al. 2003; Traverso et al. 2003; Zúñiga et al. 2004). The third state is revealed by the structure of cmCLC (Fig. 1F): in this configuration a Cl occupies Sex while Gluex slides into Scen, where it is presumably stabilized by a hydrogen bond with Tyrcen (Feng et al. 2010), and occludes the pathway towards the intracellular side.

The three binding sites display distinct ion coordination: anions bound to Scen are coordinated by the hydroxyl oxygen atoms of Sercen and Tyrcen and by the main-chain amide nitrogen atoms of G149, I356 and F357 (CLC-ec1 numbering) (Dutzler et al. 2002). In contrast anions in Sex and Sin are mostly coordinated by backbone atoms, with the exception of a hydrogen bond between Sercen and a Cl in Sin, and remain partly hydrated (Dutzler et al. 2003; Lobet & Dutzler, 2006). Two of the three sites, Scen and Sex, have similar Cl binding affinities, Kd ∼1 mm, while Sin binds ions very weakly, Kd > 30 mm (Lobet & Dutzler, 2006; Picollo et al. 2009). Ion binding to Scen is disrupted when Tyrcen is replaced by residues with smaller side chains, such as leucine or alanine, with the former increasing the Kd to ∼4 mm and the latter abolishing binding almost completely (Picollo et al. 2009). While mutations that selectively affect ion binding to Sin have not yet been identified, the S107G/Y445A/E148A triple mutant of CLC-ec1 simultaneously disrupts Scen and Sin (Lobet & Dutzler, 2006), suggesting that Sercen might be important for binding to Sin. It is not known whether the S107G mutation alone is sufficient to disrupt Sin, but the S107P mutant nearly eliminates Cl binding in CLC-ec1 suggesting that this residue might play a role in regulating ion binding to both Sin and Scen (Picollo et al. 2009).

Tunable substrate specificity of the ion pathway

Despite poor sequence conservation among CLC family members, the residues that directly line the ion binding/transport pathway are relatively well conserved, for example the amino acids that form Scen are among the most highly conserved within the family: Sercen is found in ∼42% of the deposited CLC sequences, Gluex in ∼88%, F357 in ∼57%, while at position 356 I, L or V are found in 73% of the sequences. Consistent with these observations, most CLCs share a signature selectivity sequence of SCN > Cl > Br > NO3 > F > I (Jentsch et al. 1995; Rychkov et al. 1998; Accardi et al. 2004; Nguitragool & Miller, 2006), regardless of whether they are channels or transporters. The two notable exceptions to this pattern yielded surprising insights into the mechanisms of substrate selectivity in the CLC family: atCLC-a, a homologue from the plant Arabidopsis thaliana, is a 2:1 NO3:H+ exchanger (De Angeli et al. 2006) and members of a newly identified clade of prokaryotic CLCs, the CLC-F, are fluoride selective and operate as 1:1 F:H+ exchangers (Stockbridge et al. 2012).

While the CLCs have three anionic binding sites, it appears that Scen is primarily responsible for their inter-anionic selectivity as neither Sex nor Sin are very selective (Picollo et al. 2009), with the latter displaying a slight preference for SCN over Cl (Nguitragool & Miller, 2006; Picollo et al. 2009). Ions bound to Scen are coordinated by a combination of backbone and side chain interactions (Fig. 1D). Consistent with early electrophysiological work, Sercen is the most important determinant of substrate specificity in both the CLC channels and transporters: its replacement with a proline in the CLC-5 and CLC-ec1 transporters and in the CLC-0 channel switches selectivity from Cl to NO3 (Bergsdorf et al. 2009; Picollo et al. 2009; Zifarelli & Pusch, 2009a) and conversely, the P160S mutant of atCLC-a is Cl selective rather than NO3 selective like its WT counterpart and impairs the ability of plants expressing this mutant to accumulate NO3 in vacuoles (Bergsdorf et al. 2009; Wege et al. 2010).

Interestingly, the newly identified CLC-F clade of transporters diverge drastically from their Cl or NO3 selective counterparts in the C–D loop where Sercen is located. In these transporters, the canonical G(S/P)GIP sequence is replaced by X-G(N/M)X and helix C is shortened by three amino acids (Stockbridge et al. 2012; Brammer et al. 2014), possibly enlarging the cavity around Scen. Thus, more drastic structural rearrangements might be needed to accommodate F ions rather than Cl or NO3, likely to be because of the higher energy costs associated to F dehydration, ΔH ∼−125 kcal mol−1, compared to Cl, ∼90 kcal mol−1. How the CLC-Fs succeed in selectively dehydrating, binding and transporting F but not Cl remains unclear as does whether permeating F ions need to shed their water molecules.

Taken together these results indicate that the substrate specificity of the CLCs is remarkably tunable and that, unlike what is seen in K+ and Na+ channels (Doyle et al. 1998; Zhou et al. 2001; Payandeh et al. 2011), specific interactions between side chains and the ions themselves play a key role in determining the selectivity of these transport proteins. The varied and tunable substrate specificity of the CLC family allows them to adapt and fulfil diverse physiological roles, such as controlling Cl homeostasis in cellular compartments, nutrient accumulation and extrusion of the toxic F ion from the cytosol of bacteria.

Gating mechanisms

Two mechanisms regulate gating of the CLC channels and transporters: a common gate, which simultaneously regulates the activity of both monomers, and a single pore gate, which regulates the activity of the individual subunits (Miller, 1982; Jentsch et al. 1990). In most CLCs, both processes are voltage dependent, although even the sign of this dependence varies between different homologues (Accardi & Pusch, 2000; Niemeyer et al. 2003, 2009; Zúñiga et al. 2004; de Santiago et al. 2005; Ludwig et al. 2013). Opening of the common gate requires a concerted conformational change of both subunits and involves both the transmembrane and C-termini (Bykova et al. 2006; Garcia-Olivares et al. 2008). In contrast, gating of the individual monomers entails rearrangements of a smaller scale (Dutzler et al. 2003). In addition to voltage, the CLCs are also modulated by changes in the intra- and extracellular concentrations of H+ and Cl (Hanke & Miller, 1983; Pusch et al. 1995; Chen & Miller, 1996; Rychkov et al. 1998; Chen & Chen, 2001, 2003; Zdebik et al. 2008; Zifarelli et al. 2008; Picollo et al. 2010; Leisle et al. 2011). While each homologue has distinct properties, gating of the CLC channels shares many characteristics with the transport cycle of the transporters, suggesting a strong evolutionary link between channel opening and the transport cycle (Miller, 2006).

The available crystal structures have provided insights into the ion conduction and selectivity mechanisms and, together with extensive functional work, have highlighted the central role played by Gluex in CLC channel gating and transport: in order for the channels to gate or for coupled transport to occur this position must be occupied by a protonatable residue (Dutzler et al. 2003; Traverso et al. 2003, 2006; Accardi & Miller, 2004; Feng et al. 2010). However, since the transmembrane regions of the various homologues and mutants adopt identical conformations, the question of what, if any, conformational changes – in addition to the above described movement of Gluex – are required for transport remains open. The lack of crystallographically resolved structural rearrangements led to the hypothesis that Gluex is the sole gate regulating ion flux through both CLC channels and transporters and that its movements in and out of the pathway (Fig. 1D–F) are the only relevant conformational changes taking place during gating (Dutzler et al. 2003; Feng et al. 2010, 2012). This minimal gating mechanism is consistent with functional investigations showing that each subunit functions independently (Robertson et al. 2010) and that transport does not require major conformational rearrangements between them (Nguitragool & Miller, 2007; Zdebik et al. 2008). A single gate hypothesis is also appealing as it readily rationalizes how one structural scaffold can support both secondary active transport and passive diffusion. However, such a mechanism breaks one of the basic rules of active transport: substrates should never be in simultaneous contact with both sides of the membrane (Jardetzky, 1966). Violation of this rule would result in uncontrolled substrate slippage, causing the dissipation of the gradients that the transporters create. Indeed, in most transporters extensive conformational rearrangements ensure the alternate exposure of substrates (Morth et al. 2007; Olesen et al. 2007; Reyes et al. 2009; Forrest et al. 2011; Kaback et al. 2011; Krishnamurthy & Gouaux, 2012; Perez et al. 2012; Shi, 2013) and disruption of these coordinated movements adversely impacts function. Thus, a mechanism to prevent free diffusion and slippage is necessary.

Recently, two models have been proposed to solve this conundrum. In the first model (Fig. 2A) ion movement is regulated at one end of the pathway by Gluex and at the other by a static kinetic barrier (Feng et al. 2010, 2012), possibly formed by the steric constriction in the Cl transport pathway created by Sercen and Tyrcen. This barrier slows free diffusion of Cl enough that during a protonation–deprotonation event of Gluex, only two Cl ions, on average, will go through the ‘open’ CLC transporter. The second, more conventional, model (Fig. 2B) proposes that in addition to the Gluex gate the CLCs also have an intracellular gate (i.e. a barrier whose height depends on the state of the transporter) which is formed by Tyrcen. I will describe the two models and discuss their relative strengths and weaknesses.

Figure 2.

Figure 2

Models for the transport cycle of the 2 Cl: 1 H+ CLC exchangers

A, Model I is drawn according to the proposal of Feng et al. (2010). B, Model II is drawn according to the proposal of Basilio et al. (2014).

The six states comprising Model I (Fig. 2A) are based on the crystal structures of cmCLC and CLC-ec1: states I and II reflect the unprotonated and protonated forms of the conformation observed in CmCLC (Fig. 1F), state III is a transient intermediate towards states IV and V, which respectively correspond to the protonated and unprotonated conformation of the E148Q mutant of CLC-ec1 (Fig. 1E), and state VI represents the structure of WT CLC-ec1 (Fig. 1D). The cycle starts when an intracellular proton reaches Gluex, which occupies Scen (I–II), leading to its displacement (II–III) allowing two Cl ions to enter the ion pathway from the extracellular side (III–IV). Deprotonation of Gluex (IV–V) favours its transition back into the permeation pathway displacing two Cl ions towards the intracellular side (V–VI–I). In this scheme the key variable is the balance between the height of the kinetic barrier and the deprotonation rate of Gluex in state IV. The former has to be sufficiently high to prevent significant diffusion of Cl while Gluex is protonated and at the same time is has to be sufficiently low to allow for the rapid turnover seen in some CLCs. Simulations show that this model accounts for the fundamental properties of the CLC exchangers: their 2 Cl:1 H+ stoichiometry and the ability of either ion to drive uphill transport of the other (Feng et al. 2010, 2012). Importantly, model I is also appealing for its unifying view of the CLC channels and transporters, as the former are nothing more than CLCs in which the intracellular kinetic barrier is so low that millions of ions can cross it during a protonation event of Gluex. However, Model I does not capture well other key properties of the CLCs. For example, it predicts that the transporters should become progressively uncoupled in acidic environments, while CLC-ec1 remains coupled at pH values as low as 3 (Accardi et al. 2004; Accardi & Miller, 2004) and most CLC transporters carry out their physiological functions in acidic environments. Similarly, it is not clear how in Model I the stoichiometry can remain constant when the turnover rate of the transporters varies by over three orders of magnitude, from ∼10 s−1 to ∼104 s−1, between different CLC homologues (Accardi & Miller, 2004; Zdebik et al. 2008; Jayaram et al. 2011; Phillips et al. 2012). Finally, the extremely local conformational changes assumed in Model I (just the movement of Gluex) are difficult to reconcile with experiments showing that conformational changes in regions distal to the ion pathway occur during transport (Accardi & Pusch, 2003; Bell et al. 2006; Osteen & Mindell, 2008; Elvington et al. 2009). Despite these shortcomings, Model I is appealing for its elegant simplicity and because it quantitatively reproduces some of the key features of the CLC transporters.

More recently, a second model has been proposed to describe transport by the CLCs (Fig. 2B) (Basilio et al. 2014). This model accounts for the finding that Tyrcen (and possibly other residues nearby) act as the intracellular gate of the CLC exchangers and that a conformational change of helix O is required for transport, likely as a step in the allosteric pathway coupling the inner and outer gates. These new findings led to the formulation of an alternative model. In Model II, state I represents the transporter in its apo and occluded state. Opening of the inner gate (I–II) allows two Cl ions to bind from the intracellular side displacing Gluex (II–III). This favours its protonation from the outside and triggers the closure of the inner gate, thus yielding a fully loaded state of the transporter in its outward-facing conformation (III–IV). Then Gluex re-enters the ion transport pathway, while still protonated (IV–V), and the proton is transferred from Gluex to the intracellular solution via the internal glutamate (E203 in CLC-ec1) (V–VI) to be released towards the intracellular solution and returning the transporter to its apo configuration (VI–I). In addition to describing the basic features of CLC transport, such as the stoichiometry and the tight coupling, Model II also captures some of the more unusual mechanistic features of the CLCs. For example, the synergism between Cl and H+ binding gives rise to a fully loaded state (IV) in which 2 Cl and 1 H+ are simultaneously bound to the transporter38, a state that is explicitly forbidden for classical ‘ping-pong’ alternating access exchange mechanisms. Within the framework of Model II, the CLC channels would originate from transporters in which the coupling between the two gates is lost. Consistent with this hypothesis, recent work has shown that in the muscle homologue CLC-1, Tyrcen plays a key role in the common pore gate (Bennetts & Parker, 2013). One of the key features of Model II is that Tyrcen serves as the pH-independent inner gate, a structural element that would allow the CLCs to maintain a constant exchange stoichiometry regardless of pH and of the turnover rate. In order to function, however, Model II makes several assumptions that require further testing: first, what triggers opening of the inner gate in the apo state (I–II)? Second, how are the two gates coupled? Besides the observation that helix O plays a role in this process (Basilio et al. 2014), there is no clear evidence in the literature suggesting how this could occur or if the gates are coupled solely via the ions in the permeation pathway.

Despite their significant differences, both models share numerous similarities and capture the essential features of the CLC transporters (exchange stoichiometry and tight coupling) as well as offering reasonable frameworks for the evolutionary relationship between the channels and exchangers found within the CLC family. Both models also make some assumptions that remain untested and additional work is required to further refine our understanding of how these proteins gate.

Structure of the cytoplasmic domains

In addition to the membrane-embedded transport domain, all eukaryotic CLCs and nearly half of the prokaryotic ones have large cytoplasmic domains which contain two cystathionine β-synthetase (CBS) domains. These domains regulate transport of both CLC channels and exchangers and numerous disease-causing mutations cluster to the CBS regions. Indeed, nucleotide binding to these domains regulates the activity of CLC-1 (Bennetts et al. 2005, 2007, 2012; Tseng et al. 2007; Zhang et al. 2008), CLC-5 (Wellhauser et al. 2006; Meyer et al. 2007; Zifarelli & Pusch, a2009; Wellhauser et al. 2011) and atCLC-a (De Angeli et al. 2009) and conformational changes in these regions have been linked to common gating in CLC-0 and CLC-1 (Bykova et al. 2006). Furthermore, mutations in the CBS domains of the channels CLC-1 and CLC-Ka/-Kb respectively cause dominantly inherited myotonia (Thomsen’s disease) (Steinmeyer et al. 1991; Pusch, 2002; Estévez et al. 2004) and Bartter’s syndrome (Estévez et al. 2001; Krämer et al. 2008). Similarly, mutations in the cytosolic regions of the CLC-5 and CLC-7 exchangers result in Dent’s disease (Lloyd et al. 1996, 1997a,b1997) and infantile malignant osteopetrosis (Kornak et al. 2001, 2006).

The structures of the isolated CBS domains from CLC-0, CLC-Ka and CLC-5 (Meyer & Dutzler, 2006; Markovic & Dutzler, 2007; Meyer et al. 2007) together with the recent structure of the full length eukaryotic transporter cmCLC (Feng et al. 2010) revealed the molecular organization of these cytosolic regions and their interactions with the transmembrane domain (Fig. 1C). The CBS are small domains, ∼50 amino acids long, with low sequence conservation and characterized by a fold composed of three β strands and two α helices (Estévez et al. 2004). The cytoplasmic domains of CLC-5 (Fig. 3A) and cmCLC (Fig. 3B) show that the C-termini assemble to form a dimer with an extensive interaction surface, mostly formed by the β2 and β3 sheets of the CBS2 domains, and characterized by a 2-fold axis of non-crystallographic symmetry. Mutagenesis, crosslinking and analytical ultracentrifugation experiments demonstrated that this surface is conserved also in CLC-0, even though its cytoplasmic domain crystallized in monomeric form (Markovic & Dutzler, 2007).

Figure 3.

Figure 3

Structures of the CBS domains with and without ATP

A, structure of the isolated CBS domains from CLC-5. Bound ATP molecules are shown as CPK coloured, spacefilled models. B, structure of the CBS domains of cmCLC. C, close up view of the interactions between the C-terminal and TM domains of cmCLC. The important helices are labelled. D, detailed view of the interactions between ATP and the CBS domains of CLC-5: the α-helices and β-sheets from each CBS domain are coloured (the α-helices from CBS1 and 2 are respectively shown in yellow and orange and the β-sheets are shown in green and cyan). For clarity only the secondary structural elements from CBS1 are labelled. The ATP molecule is shown as a CPK coloured, spacefilled model. PDB ID: WT cmCLC (3ORG) and the isolated C-terminus of CLC-5 in complex with ATP (2J91).

In cmCLC the extensive interactions between the transmembrane domain and the cytosolic region are mostly mediated by CBS2, while CBS1 is located far from the membrane and the linker connecting it to helix R winds around CBS2 (Fig. 3C). The extensive interface between the TM and cytosolic regions of cmCLC has a high complementarity index indicating a tight interaction between the two regions (Feng et al. 2010). The CBS domains interact with the cmCLC TM region at three locations (Fig. 3C): helix R is directly connected to CBS1, CBS2 contacts helix D and the loop connecting helices H and I at the dimer interface. Since helices D and R directly line the ion pathway, respectively contributing Sercen and Tyrcen (Fig. 1D), it is plausible to hypothesize these contacts are responsible for transducing rearrangements of the CBS domains directly to the ion pathway. Similarly, the contact between CBS2 and the H–I loop can rationalize how the cytosolic domains influence processes involving both subunits, such as the common gating process displayed by CLC channels. Indeed, several mutations in human CLCs that are thought to act through the common gate localize to the inter-subunit interface between the TM and CBS domains (Estévez & Jentsch, 2002; Feng et al. 2010).

Structural basis of nucleotide gating of the CLCs

Although the structure of the full length cmCLC and those of the isolated domains revealed the molecular organization of these domains, the mechanisms by which the CBS domains modulate transport remain to be elucidated. Recent findings showing that nucleotides regulate CLC gating by binding to the cytosolic CBS domains (Bennetts et al. 2005, 2007, 2012; Wellhauser et al. 2006; Meyer et al. 2007; Tseng et al. 2007; Zhang et al. 2008; De Angeli et al. 2009; Zifarelli & Pusch, 2009a). Interestingly, ATP binding to different CLC homologues elicits divergent responses: it inhibits the CLC-1 channel and the atCLC-a exchanger while it potentiates the CLC-5 transporter. Despite these differences, the interactions of the nucleotides with the CBS domains of the CLCs share the same basic characteristics: binding occurs with low affinity (100–1000 μm), nucleotides with the same base bind with similar affinities (irrespective of the number of phosphates), the binding site is non-catalytic, and the nucleotides are allosteric modulators of the common gate (Bennetts et al. 2007; De Angeli et al. 2009; Zifarelli & Pusch, 2009b). Not all CLCs bind and are modulated by nucleotides, for example CLC-0, CLC-Ka, CLC-7 and cmCLC are unaffected by ATP or its analogues (Meyer & Dutzler, 2006; Markovic & Dutzler, 2007; Feng et al. 2010; Leisle et al. 2011).

The structures of the C-terminal domain of CLC-5 in complex with ATP (Fig. 3D) or with ADP revealed the principles of nucleotide binding to the CLC CBS domains. The nucleotide binding site is located at the interface between CBS1 and -2 in a head-in configuration (Fig. 3D) with the adenine base inserted into a deep crevice formed by hydrophobic residues from both CBS domains. The phosphate tail is partly water exposed and makes only weak contacts with the protein, rationalizing the observation that ATP, ADP and AMP have similar affinities for CLC-5 and CLC-1 (Bennetts et al. 2005; Meyer et al. 2007) while nucleotides with different bases (cAMP, IMP and GTP) bind weakly or are inert (Bennetts et al. 2005).

Functionally, nucleotides have very diverse effects on different CLC homologues. While application of millimolar concentrations of intracellular ATP potentiates CLC-5 currents by increasing the probability of the transporter to be in an active conformation (Zifarelli & Pusch, b2009) the same manoeuvre inhibits the skeletal muscle channel CLC-1 by reducing the open probability of the common pore gate (Bennetts et al. 2005). This inhibitory action is exerted through two distinct mechanisms: ATP shifts activations towards positive voltages and lowers the minimal open probability of the common gate. The inhibitory potency of ATP strongly depends on pH and redox potential (Bennetts et al. 2007; Tseng et al. 2007; Zhang et al. 2008). Despite extensive mutagenesis experiments, the amino acids responsible for these modulatory effects have not yet been identified suggesting that multiple residues might be involved in these processes (Zhang et al. 2008). While the precise physiological implications of the nucleotide modulation of CLC-1 remain to be elucidated, it has been proposed that they would allow the channel to be a finely tuned sensor of the metabolic state of skeletal muscle cells. Finally, the plant CLC homologue atCLC-a is inhibited by saturating intracellular ATP, for a ∼2-fold reduction in current (De Angeli et al. 2009). In contrast to CLC-1 and CLC-5, in which only the nucleotide base matters, for atCLC-a the number of phosphates in the nucleotides also play a key role: ATP inhibits transport, ADP is inert and AMP, while incapable of eliciting a response on its own, competes with ATP and diminishes its inhibitory effect (De Angeli et al. 2009). The structural bases for the differential effects of nucleotides on atCLC-a remain unclear since all key residues for nucleotide binding are conserved and homology modelling suggested that nucleotides bind to the two domains in similar configurations.

Outlook

Ten years after the molecular identification of CLC-0, the first high-resolution structure of a CLC transport protein completely revolutionized our understanding of CLC function. In the nearly 15 years since, numerous structures elucidated the complex architecture of the CLCs, allowed the identification of key regions regulating transport, provided glimpses into the selectivity mechanism and revealed the basis for nucleotide binding and modulation. The unexpected discovery that the CLC family is split between channels and exchangers provided insights into the mechanistic boundary separating these two types of transport proteins and upended our understanding of the physiological roles of intracellular CLCs. Yet, despite these major strides, the original and fundamental question of what does a CLC channel look like remains unanswered. Which structural features distinguish the channels from the exchangers? What rearrangements occur during transport and gating? Answering these questions is likely to lead to more unexpected discoveries and point us in unforeseeable directions.

Biography

Alessio Accardi received his undergraduate education in Physics at the University of Rome I ‘La Sapienza’ and a PhD in Biophysics from the University of Genoa with Michael Pusch. After 5 years of postdoctoral work at Brandeis University with Christopher Miller he began his independent career in 2007 as an Assistant Professor in the Department of Physiology and Biophysics at the University of Iowa. In 2010 he moved to the Department of Anaesthesiology at Weill Cornell Medical College. His research focuses on elucidating the mechanistic bases of ion and lipid transport across biological membranes. To achieve these goals he combines electrophysiological measurements of channels and transporters in cells and reconstituted membranes with X-ray crystallography, membrane protein purification and reconstitution, and lipid transport assays. Inline graphic

Additional information

Competing interests

There are no competing financial interests.

References

  1. Accardi A, Kolmakova-Partensky L, Williams C. Miller C. Ionic currents mediated by a prokaryotic homologue of CLC Cl− channels. J Gen Physiol. 2004;123:109–119. doi: 10.1085/jgp.200308935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Accardi A. Miller C. Secondary active transport mediated by a prokaryotic homologue of ClC Cl− channels. Nature. 2004;427:803–807. doi: 10.1038/nature02314. [DOI] [PubMed] [Google Scholar]
  3. Accardi A. Pusch M. Fast and slow gating relaxations in the muscle chloride channel CLC-1. J Gen Physiol. 2000;116:433–444. doi: 10.1085/jgp.116.3.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Accardi A. Pusch M. Conformational changes in the pore of CLC-0. J Gen Physiol. 2003;122:277–293. doi: 10.1085/jgp.200308834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Basilio D, Noack K, Picollo A. Accardi A. Conformational changes required for H+/Cl− exchange mediated by a CLC transporter. Nat Struct Mol Biol. 2014;21:456–463. doi: 10.1038/nsmb.2814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bell SP, Curran PK, Choi S. Mindell JA. Site-directed fluorescence studies of a prokaryotic ClC antiporter. Biochemistry. 2006;45:6773–6782. doi: 10.1021/bi0523815. [DOI] [PubMed] [Google Scholar]
  7. Bennetts B. Parker MW. Molecular determinants of common gating of a ClC chloride channel. Nat Commun. 2013;4:2507. doi: 10.1038/ncomms3507. [DOI] [PubMed] [Google Scholar]
  8. Bennetts B, Parker MW. Cromer BA. Inhibition of skeletal muscle CLC-1 chloride channels by low intracellular pH and ATP. J Biol Chem. 2007;282:32780–32791. doi: 10.1074/jbc.M703259200. [DOI] [PubMed] [Google Scholar]
  9. Bennetts B, Rychkov GY, Ng H-L, Morton CJ, Stapleton D, Parker MW. Cromer BA. Cytoplasmic ATP-sensing domains regulate gating of skeletal muscle ClC-1 chloride channels. J Biol Chem. 2005;280:32452–32458. doi: 10.1074/jbc.M502890200. [DOI] [PubMed] [Google Scholar]
  10. Bennetts B, Yu Y, Chen TY. Parker MW. Intracellular β-nicotinamide adenine dinucleotide inhibits the skeletal muscle ClC-1 chloride channel. J Biol Chem. 2012;287:25808–25820. doi: 10.1074/jbc.M111.327551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bergsdorf EY, Zdebik AA. Jentsch TJ. Residues important for nitrate/proton coupling in plant and mammalian CLC transporters. J Biol Chem. 2009;284:11184–11193. doi: 10.1074/jbc.M901170200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brammer AE, Stockbridge RB. Miller C. F−/Cl− selectivity in CLCF-type F−/H+ antiporters. J Gen Physiol. 2014;144:129–136. doi: 10.1085/jgp.201411225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bykova EA, Zhang XD, Chen TY. Zheng J. Large movement in the C terminus of CLC-0 chloride channel during slow gating. Nat Struct Mol Biol. 2006;13:1115–1119. doi: 10.1038/nsmb1176. [DOI] [PubMed] [Google Scholar]
  14. Chen MF. Chen TY. Different fast-gate regulation by external Cl− and H+ of the muscle-type ClC chloride channels. J Gen Physiol. 2001;118:23–32. doi: 10.1085/jgp.118.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chen MF. Chen TY. Side-chain charge effects and conductance determinants in the pore of ClC-0 chloride channels. J Gen Physiol. 2003;122:133–145. doi: 10.1085/jgp.200308844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chen TY. Miller C. Nonequilibrium gating and voltage dependence of the ClC-0 Cl− channel. J Gen Physiol. 1996;108:237–250. doi: 10.1085/jgp.108.4.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. De Angeli A, Monachello D, Ephritikhine G, Frachisse JM, Thomine S, Gambale F. Barbier-Brygoo H. The nitrate/proton antiporter AtCLCa mediates nitrate accumulation in plant vacuoles. Nature. 2006;442:939–942. doi: 10.1038/nature05013. [DOI] [PubMed] [Google Scholar]
  18. De Angeli A, Moran O, Wege S, Filleur S, Ephritikhine G, Thomine S, Barbier-Brygoo H. Gambale F. ATP binding to the C terminus of the Arabidopsis thaliana nitrate/proton antiporter, AtCLCa, regulates nitrate transport into plant vacuoles. J Biol Chem. 2009;284:26526–26532. doi: 10.1074/jbc.M109.005132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. de Santiago JA, Nehrke K. Arreola J. Quantitative analysis of the voltage-dependent gating of mouse parotid ClC-2 chloride channel. J Gen Physiol. 2005;126:591–603. doi: 10.1085/jgp.200509310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT. MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998;280:69–77. doi: 10.1126/science.280.5360.69. [DOI] [PubMed] [Google Scholar]
  21. Dutzler R, Campbell EB, Cadene M, Chait BT. MacKinnon R. X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature. 2002;415:287–294. doi: 10.1038/415287a. [DOI] [PubMed] [Google Scholar]
  22. Dutzler R, Campbell EB. MacKinnon R. Gating the selectivity filter in ClC chloride channels. Science. 2003;300:108–112. doi: 10.1126/science.1082708. [DOI] [PubMed] [Google Scholar]
  23. Elvington S, Liu C. Maduke M. Substrate-driven conformational changes in ClC-ec1 observed by fluorine NMR. EMBO J. 2009;28:3090–3102. doi: 10.1038/emboj.2009.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Estévez R, Boettger T, Stein V, Birkenhäger R, Otto E, Hildebrandt F. Jentsch TJ. Barttin is a Cl− channel β-subunit crucial for renal Cl− reabsorption and inner ear K+ secretion. Nature. 2001;414:558–561. doi: 10.1038/35107099. [DOI] [PubMed] [Google Scholar]
  25. Estévez R. Jentsch TJ. CLC chloride channels: correlating structure with function. Curr Opin Struct Biol. 2002;12:531–539. doi: 10.1016/s0959-440x(02)00358-5. [DOI] [PubMed] [Google Scholar]
  26. Estévez R, Pusch M, Ferrer-Costa C, Orozco M. Jentsch TJ. Functional and structural conservation of CBS domains from CLC channels. J Physiol. 2004;557:363–378. doi: 10.1113/jphysiol.2003.058453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Feng L, Campbell EB, Hsiung Y. MacKinnon R. Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle. Science. 2010;330:635–641. doi: 10.1126/science.1195230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Feng L, Campbell EB. MacKinnon R. Molecular mechanism of proton transport in CLC Cl−/H+ exchange transporters. Proc Natl Acad Sci USA. 2012;109:11699–11704. doi: 10.1073/pnas.1205764109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Forrest LR, Krämer R. Ziegler C. The structural basis of secondary active transport mechanisms. Biochem Biophys Acta. 2011;1807:167–188. doi: 10.1016/j.bbabio.2010.10.014. [DOI] [PubMed] [Google Scholar]
  30. Forrest LR. Rudnick G. The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters. Physiology (Bethesda) 2009;24:377–386. doi: 10.1152/physiol.00030.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Fu D, Libson A, Miercke LJ, Weitzman C, Nollert P, Krucinski J. Stroud RM. Structure of a glycerol-conducting channel and the basis for its selectivity. Science. 2000;290:481–486. doi: 10.1126/science.290.5491.481. [DOI] [PubMed] [Google Scholar]
  32. Garcia-Olivares J, Alekov A, Boroumand MR, Begemann B, Hidalgo P. Fahlke C. Gating of human ClC-2 chloride channels and regulation by carboxy-terminal domains. J Physiol. 2008;586:5325–5336. doi: 10.1113/jphysiol.2008.158097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hanke W. Miller C. Single chloride channels from Torpedo electroplax. Activation by protons. J Gen Physiol. 1983;82:25–45. doi: 10.1085/jgp.82.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Jardetzky O. Simple allosteric model for membrane pumps. Nature. 1966;211:969–970. doi: 10.1038/211969a0. [DOI] [PubMed] [Google Scholar]
  35. Jayaram H, Robertson JL, Wu F, Williams C. Miller C. Structure of a slow CLC Cl¯/H+ antiporter from a cyanobacterium. Biochemistry. 2011;50:788–794. doi: 10.1021/bi1019258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Jentsch TJ. CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol. 2008;43:3–36. doi: 10.1080/10409230701829110. [DOI] [PubMed] [Google Scholar]
  37. Jentsch TJ, Günther W, Pusch M. Schwappach B. Properties of voltage-gated chloride channels of the ClC gene family. J Physiol. 1995;482:19S–25S. doi: 10.1113/jphysiol.1995.sp020560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Jentsch TJ, Steinmeyer K. Schwarz G. Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature. 1990;348:510–514. doi: 10.1038/348510a0. [DOI] [PubMed] [Google Scholar]
  39. Kaback HR, Smirnova I, Kasho V, Nie Y. Zhou Y. The alternating access transport mechanism in LacY. J Membr Biol. 2011;239:85–93. doi: 10.1007/s00232-010-9327-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kornak U, Kasper D, Bösl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G. Jentsch TJ. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104:205–215. doi: 10.1016/s0092-8674(01)00206-9. [DOI] [PubMed] [Google Scholar]
  41. Kornak U, Ostertag A, Branger S, Benichou O. de Vernejoul MC. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J Clin Endocrinol Metab. 2006;91:995–1000. doi: 10.1210/jc.2005-2017. [DOI] [PubMed] [Google Scholar]
  42. Krämer BK, Bergler T, Stoelcker B. Waldegger S. Mechanisms of disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance. Nat Clin Pract Nephrol. 2008;4:48–57. doi: 10.1038/ncpneph0689. [DOI] [PubMed] [Google Scholar]
  43. Krishnamurthy H. Gouaux E. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature. 2012;481:469–474. doi: 10.1038/nature10737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Leisle L, Ludwig CF, Wagner FA, Jentsch TJ. Stauber T. ClC-7 is a slowly voltage-gated 2Cl−/1H+-exchanger and requires Ostm1 for transport activity. EMBO J. 2011;30:2140–2152. doi: 10.1038/emboj.2011.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lloyd SE, Günther W, Pearce SH, Thomson A, Bianchi ML, Bosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch TJ. Thakker RV. Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet. 1997;6:1233–1239. doi: 10.1093/hmg/6.8.1233. [DOI] [PubMed] [Google Scholar]
  46. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW. Thakker RV. A common molecular basis for three inherited kidney stone diseases. Nature. 1996;379:445–449. doi: 10.1038/379445a0. [DOI] [PubMed] [Google Scholar]
  47. Lloyd SE, Pearce SH, Günther W, Kawaguchi H, Igarashi T, Jentsch TJ. Thakker RV. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5) J Clin Invest. 1997;99:967–974. doi: 10.1172/JCI119262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Lobet S. Dutzler R. Ion-binding properties of the ClC chloride selectivity filter. EMBO J. 2006;25:24–33. doi: 10.1038/sj.emboj.7600909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ludewig U, Pusch M. Jentsch TJ. Two physically distinct pores in the dimeric ClC-0 chloride channel. Nature. 1996;383:340–343. doi: 10.1038/383340a0. [DOI] [PubMed] [Google Scholar]
  50. Ludwig CF, Ullrich F, Leisle L, Stauber T. Jentsch TJ. Common gating of both CLC transporter subunits underlies voltage-dependent activation of the 2Cl−/1H+ exchanger ClC-7/Ostm1. J Biol Chem. 2013;288:28611–28619. doi: 10.1074/jbc.M113.509364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Maduke M, Pheasant DJ. Miller C. High-level expression, functional reconstitution, and quaternary structure of a prokaryotic ClC-type chloride channel. J Gen Physiol. 1999;114:713–722. doi: 10.1085/jgp.114.5.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Markovic S. Dutzler R. The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface. Structure. 2007;15:715–725. doi: 10.1016/j.str.2007.04.013. [DOI] [PubMed] [Google Scholar]
  53. Meyer S. Dutzler R. Crystal structure of the cytoplasmic domain of the chloride channel ClC-0. Structure. 2006;14:299–307. doi: 10.1016/j.str.2005.10.008. [DOI] [PubMed] [Google Scholar]
  54. Meyer S, Savaresi S, Forster IC. Dutzler R. Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5. Nat Struct Mol Biol. 2007;14:60–67. doi: 10.1038/nsmb1188. [DOI] [PubMed] [Google Scholar]
  55. Middleton RE, Pheasant DJ. Miller C. Homodimeric architecture of a ClC-type chloride ion channel. Nature. 1996;383:337–340. doi: 10.1038/383337a0. [DOI] [PubMed] [Google Scholar]
  56. Miller C. Open-state substructure of single chloride channels from Torpedo electroplax. Philos Trans R Soc Lond B Biol Sci. 1982;299:401–411. doi: 10.1098/rstb.1982.0140. [DOI] [PubMed] [Google Scholar]
  57. Miller C. ClC chloride channels viewed through a transporter lens. Nature. 2006;440:484–489. doi: 10.1038/nature04713. [DOI] [PubMed] [Google Scholar]
  58. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sørensen TL, Petersen J, Andersen JP, Vilsen B. Nissen P. Crystal structure of the sodium-potassium pump. Nature. 2007;450:1043–1049. doi: 10.1038/nature06419. [DOI] [PubMed] [Google Scholar]
  59. Nguitragool W. Miller C. Uncoupling of a CLC Cl−/H+ exchange transporter by polyatomic anions. J Mol Biol. 2006;362:682–690. doi: 10.1016/j.jmb.2006.07.006. [DOI] [PubMed] [Google Scholar]
  60. Nguitragool W. Miller C. CLC Cl− /H+ transporters constrained by covalent cross-linking. Proc Natl Acad Sci USA. 2007;104:20659–20665. doi: 10.1073/pnas.0708639104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Niemeyer MI, Cid LP, Yusef YR, Briones R. Sepúlveda FV. Voltage-dependent and -independent titration of specific residues accounts for complex gating of a ClC chloride channel by extracellular protons. J Physiol. 2009;587:1387–1400. doi: 10.1113/jphysiol.2008.167353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Niemeyer MI, Cid LP, Zúñiga L, Catalán M. Sepúlveda FV. A conserved pore-lining glutamate as a voltage- and chloride-dependent gate in the ClC-2 chloride channel. J Physiol. 2003;553:873–879. doi: 10.1113/jphysiol.2003.055988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Olesen C, Picard M, Winther AM, Gyrup C, Morth JP, Oxvig C, Møller JV. Nissen P. The structural basis of calcium transport by the calcium pump. Nature. 2007;450:1036–1042. doi: 10.1038/nature06418. [DOI] [PubMed] [Google Scholar]
  64. Osteen J. Mindell JA. Zn2+ inhibition of CLC-4. Biophys J. 2008;95:4668–4675. doi: 10.1529/biophysj.108.137158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Payandeh J, Scheuer T, Zheng N. Catterall WA. The crystal structure of a voltage-gated sodium channel. Nature. 2011;475:353–358. doi: 10.1038/nature10238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Perez C, Koshy C, Yildiz O. Ziegler C. Alternating-access mechanism in conformationally asymmetric trimers of the betaine transporter BetP. Nature. 2012;490:126–130. doi: 10.1038/nature11403. [DOI] [PubMed] [Google Scholar]
  67. Phillips S, Brammer AE, Rodriguez L, Lim HH, Stary-Weinzinger A. Matulef K. Surprises from an unusual CLC homolog. Biophys J. 2012;103:L44–46. doi: 10.1016/j.bpj.2012.08.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Picollo A, Malvezzi M. Accardi A. Proton block of the CLC-5 Cl−/H+ exchanger. J Gen Physiol. 2010;135:653–659. doi: 10.1085/jgp.201010428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Picollo A, Malvezzi M, Houtman JC. Accardi A. Basis of substrate binding and conservation of selectivity in the CLC family of channels and transporters. Nat Struct Mol Biol. 2009;16:1294–1301. doi: 10.1038/nsmb.1704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Pusch M. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum Mutat. 2002;19:423–434. doi: 10.1002/humu.10063. [DOI] [PubMed] [Google Scholar]
  71. Pusch M, Ludewig U, Rehfeldt A. Jentsch TJ. Gating of the voltage-dependent chloride channel CIC-0 by the permeant anion. Nature. 1995;373:527–531. doi: 10.1038/373527a0. [DOI] [PubMed] [Google Scholar]
  72. Reyes N, Ginter C. Boudker O. Transport mechanism of a bacterial homologue of glutamate transporters. Nature. 2009;462:880–885. doi: 10.1038/nature08616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Robertson JL, Kolmakova-Partensky L. Miller C. Design, function and structure of a monomeric ClC transporter. Nature. 2010;468:844–847. doi: 10.1038/nature09556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Rychkov GY, Pusch M, Roberts ML, Jentsch TJ. Bretag AH. Permeation and block of the skeletal muscle chloride channel, ClC-1, by foreign anions. J Gen Physiol. 1998;111:653–665. doi: 10.1085/jgp.111.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Shi Y. Common folds and transport mechanisms of secondary active transporters. Annu Rev Biophys. 2013;42:51–72. doi: 10.1146/annurev-biophys-083012-130429. [DOI] [PubMed] [Google Scholar]
  76. Steinmeyer K, Klocke R, Ortland C, Gronemeier M, Jockusch H, Gründer S. Jentsch TJ. Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Nature. 1991;354:304–308. doi: 10.1038/354304a0. [DOI] [PubMed] [Google Scholar]
  77. Stockbridge RB, Lim HH, Otten R, Williams C, Shane T, Weinberg Z. Miller C. Fluoride resistance and transport by riboswitch-controlled CLC antiporters. Proc Natl Acad Sci USA. 2012;109:15289–15294. doi: 10.1073/pnas.1210896109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Traverso S, Elia L. Pusch M. Gating competence of constitutively open CLC-0 mutants revealed by the interaction with a small organic inhibitor. J Gen Physiol. 2003;122:295–306. doi: 10.1085/jgp.200308784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Traverso S, Zifarelli G, Aiello R. Pusch M. Proton sensing of CLC-0 mutant E166D. J Gen Physiol. 2006;127:51–66. doi: 10.1085/jgp.200509340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Tseng P-Y, Bennetts B. Chen T-Y. Cytoplasmic ATP inhibition of CLC-1 is enhanced by low pH. J Gen Physiol. 2007;130:217–221. doi: 10.1085/jgp.200709817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wege S, Jossier M, Filleur S, Thomine S, Barbier-Brygoo H, Gambale F. De Angeli A. The proline 160 in the selectivity filter of the Arabidopsis NO3−/H+ exchanger AtCLCa is essential for nitrate accumulation in planta. Plant J. 2010;63:861–869. doi: 10.1111/j.1365-313X.2010.04288.x. [DOI] [PubMed] [Google Scholar]
  82. Wellhauser L, Kuo HH, Stratford FL, Ramjeesingh M, Huan LJ, Luong W, Li C, Deber CM. Bear CE. Nucleotides bind to the C-terminus of ClC-5. Biochem J. 2006;398:289–294. doi: 10.1042/BJ20060142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Wellhauser L, Luna-Chavez C, D’Antonio C, Tainer J. Bear CE. ATP induces conformational changes in the carboxyl-terminal region of ClC-5. J Biol Chem. 2011;286:6733–6741. doi: 10.1074/jbc.M110.175877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Yamashita A, Singh SK, Kawate T, Jin Y. Gouaux E. Crystal structure of a bacterial homologue of Na+/Cl−-dependent neurotransmitter transporters. Nature. 2005;437:215–223. doi: 10.1038/nature03978. [DOI] [PubMed] [Google Scholar]
  85. Yernool D, Boudker O, Folta-Stogniew E. Gouaux E. Trimeric subunit stoichiometry of the glutamate transporters from Bacillus caldotenax and Bacillus stearothermophilus. Biochemistry. 2003;42:12981–12988. doi: 10.1021/bi030161q. [DOI] [PubMed] [Google Scholar]
  86. Zdebik AA, Zifarelli G, Bergsdorf EY, Soliani P, Scheel O, Jentsch TJ. Pusch M. Determinants of anion-proton coupling in mammalian endosomal CLC proteins. J Biol Chem. 2008;283:4219–4227. doi: 10.1074/jbc.M708368200. [DOI] [PubMed] [Google Scholar]
  87. Zhang XD, Tseng PY. Chen TY. ATP inhibition of CLC-1 is controlled by oxidation and reduction. J Gen Physiol. 2008;132:421–428. doi: 10.1085/jgp.200810023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Zhou Y, Morais-Cabral JH, Kaufman A. MacKinnon R. Chemistry of ion coordination and hydration revealed by a K+ channel–Fab complex at 2.0 Å resolution. Nature. 2001;414:43–48. doi: 10.1038/35102009. [DOI] [PubMed] [Google Scholar]
  89. Zifarelli G, Murgia AR, Soliani P. Pusch M. Intracellular proton regulation of ClC-0. J Gen Physiol. 2008;132:185–198. doi: 10.1085/jgp.200809999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Zifarelli G. Pusch M. Conversion of the 2 Cl−/1 H+ antiporter ClC-5 in a NO3−/H+ antiporter by a single point mutation. EMBO J. 2009;10:1111–1116. doi: 10.1038/emboj.2008.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Zifarelli G. Pusch M. Intracellular regulation of human ClC-5 by adenine nucleotides. EMBO Rep. 2009;10:1111–1116. doi: 10.1038/embor.2009.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Zúñiga L, Niemeyer MI, Varela D, Catalán M, Cid LP. Sepúlveda FV. The voltage-dependent ClC-2 chloride channel has a dual gating mechanism. J Physiol. 2004;555:671–682. doi: 10.1113/jphysiol.2003.060046. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES